Skip to main content

Table 5 Comparison between both groups as regards heterogenicity and PD at 0 week and 12 weeks

From: Extracorporeal shockwave therapy versus musculoskeletal mesotherapy for Achilles tendinopathy in athlete

Variables

Group I (ESWT)

N = 20

Group II (mesotherapy)

N = 20

χ2

P value

S

Heterogenicity 0 weeks

  

1.067

0.785

NS

 0

0

1

 1

8(40%)

7(35%)

 2

7(35%)

7(35%)

 3

5(25%)

5 (25%)

Heterogenicity 12 weeks

  

0.210

0.976

NS

 0

8 (40%)

7(35%)

 1

7(35%)

7(35%)

 2

3(15%)

4(20%)

 3

2(10%)

2(10%)

 χ2

10.952

6.604

   

 P

0.012*

0.085

 S

S

NS

PD 0 weeks

  

0.00

1.00

NS

 0

13(65%)

12(60%)

   

 1

7 (35%)

8 (40%)

PD after 12 weeks

  

0.00

1.00

NS

 0

17 (85%)

15(75%)

   

 1

3(15%)

5(25%)

 χ2

0.502

0.456

   

 P

0.023*

0.499

 S

S

NS

Calcification 0 weeks

  

0.456

0.499

 

 0

12 (60%)

15 (75%)

   

 1

8(40%)

5(25%)

Calcification after 12 weeks

19 (95%)

15 (75%)

1.765

0.1840

 

 0

1(5%)

5(25%)

   

 1

     

 χ2

5.161

0.00

   

 P

0.023*

1.00

   

 S

S

NS

   
  1. PD power Doppler, S significant